Exchange Traded Concepts’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
AIM
AAMU
AAIS
BCAM
JWM
P
Exchange Traded Concepts's DGX Position: Q2 2026 in Review
Exchange Traded Concepts increased its Quest Diagnostics (DGX) stake by 8.7% in Q2 2026, buying an estimated $111K and bringing the position to 7,099 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #810.
Exchange Traded Concepts first reported a position in DGX in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.1M in Q4 2021. 243 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Exchange Traded Concepts held 7,099 shares of Quest Diagnostics worth $1.5M as of Q2 2026.
- Exchange Traded Concepts bought 566 Quest Diagnostics shares in Q2 2026, an estimated $111K.
- Quest Diagnostics made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #810 holding.
- Exchange Traded Concepts first reported a position in Quest Diagnostics in Q4 2019 and has held it in 27 quarters since.
- Exchange Traded Concepts's Quest Diagnostics position peaked at $3.1M in Q4 2021.
- 243 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.